120 related articles for article (PubMed ID: 7719726)
1. Effects of peripheral versus central administration of the endogenous glucocorticoid, corticosterone, and the glucocorticoid receptor agonist, RU 28362, on LH release in male rats.
Briski KP
Brain Res; 1995 Jan; 670(1):66-74. PubMed ID: 7719726
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of type II, but not type I glucocorticoid receptors results in elevated basal luteinizing hormone release in male rats.
Briski KP; Sylvester PW
Neuroendocrinology; 1994 Dec; 60(6):601-8. PubMed ID: 7700503
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat.
Briski KP; Vogel KL
Neuropeptides; 1995 Mar; 28(3):175-81. PubMed ID: 7791961
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory vs. inhibitory effects of acute stress on plasma LH: differential effects of pretreatment with dexamethasone or the steroid receptor antagonist, RU 486.
Briski KP
Pharmacol Biochem Behav; 1996 Sep; 55(1):19-26. PubMed ID: 8870033
[TBL] [Abstract][Full Text] [Related]
5. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin.
Hawes AS; Rock CS; Keogh CV; Lowry SF; Calvano SE
Infect Immun; 1992 Jul; 60(7):2641-7. PubMed ID: 1612734
[TBL] [Abstract][Full Text] [Related]
7. The antiglucocorticoid, RU486, attenuates stress-induced decreases in plasma-luteinizing hormone concentrations in male rats.
Briski KP; Vogel KL; McIntyre AR
Neuroendocrinology; 1995 Jun; 61(6):638-45. PubMed ID: 7659189
[TBL] [Abstract][Full Text] [Related]
8. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
Ratka A; Sutanto W; Bloemers M; de Kloet ER
Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
[TBL] [Abstract][Full Text] [Related]
9. Acute inhibition of pituitary LH release in the male rat by the glucocorticoid agonist decadron phosphate.
Briski KP; Sylvester PW
Neuroendocrinology; 1991 Oct; 54(4):313-20. PubMed ID: 1758573
[TBL] [Abstract][Full Text] [Related]
10. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.
Reul JM; de Kloet ER
Endocrinology; 1985 Dec; 117(6):2505-11. PubMed ID: 2998738
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of angiotensin II-induced drinking by glucocorticoids is a specific glucocorticoid type II receptor (GR)-mediated event.
Sumners C; Gault TR; Fregly MJ
Brain Res; 1991 Jun; 552(2):283-90. PubMed ID: 1913190
[TBL] [Abstract][Full Text] [Related]
12. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats.
Burgess LH; Handa RJ
Endocrinology; 1992 Sep; 131(3):1261-9. PubMed ID: 1324155
[TBL] [Abstract][Full Text] [Related]
13. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
[TBL] [Abstract][Full Text] [Related]
14. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
Jain MR; Pu S; Kalra PS; Kalra SP
Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
[TBL] [Abstract][Full Text] [Related]
15. Receptor specificity of a glucocorticoid- and stress-induced hippocampal protein.
Schlatter LK; Dokas LA
J Neurosci; 1989 Apr; 9(4):1134-40. PubMed ID: 2539439
[TBL] [Abstract][Full Text] [Related]
16. Biphasic effects of adrenal steroids on learned helplessness behavior induced by inescapable shock.
Kademian SM; Bignante AE; Lardone P; McEwen BS; Volosin M
Neuropsychopharmacology; 2005 Jan; 30(1):58-66. PubMed ID: 15496941
[TBL] [Abstract][Full Text] [Related]
17. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Lamberts SW; Uitterlinden P; de Jong FH
Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective type I and II adrenal steroid agonists on immune cell distribution.
Miller AH; Spencer RL; hassett J; Kim C; Rhee R; Ciurea D; Dhabhar F; McEwen B; Stein M
Endocrinology; 1994 Nov; 135(5):1934-44. PubMed ID: 7956914
[TBL] [Abstract][Full Text] [Related]
19. Corticosterone Blocks Ovarian Cyclicity and the LH Surge via Decreased Kisspeptin Neuron Activation in Female Mice.
Luo E; Stephens SB; Chaing S; Munaganuru N; Kauffman AS; Breen KM
Endocrinology; 2016 Mar; 157(3):1187-99. PubMed ID: 26697722
[TBL] [Abstract][Full Text] [Related]
20. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein.
Dayanithi G; Antoni FA
Endocrinology; 1989 Jul; 125(1):308-13. PubMed ID: 2544406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
